Status:
COMPLETED
Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy
Lead Sponsor:
University of Pittsburgh
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
This project will systematically plan and evaluate the implementation of the Transdiagnostic Sleep and Circadian Intervention for youth (TranS-CY). As an early stage study, investigators will focus on...
Detailed Description
Pre-phase (2 weeks in duration): Initial Interview: Following informed consent and enrollment, participants will complete a 45-60 minute interview with research investigators using video web conferen...
Eligibility Criteria
Inclusion
- Parents/caregivers of youth between ages 6 and 17 with a primary diagnosis of Duchenne muscular dystrophy (DMD) who lives at home .
- Access to a smart-phone or computer and internet for the weekly web-based sessions, as well as uploading of the Actigraph data;
- English speaking.
Exclusion
- Unable to speak or read English
- Their child with DMD has cognitive or behavioral concerns that would limit participation and follow-through of intervention;
- Their child/youth with DMD is currently receiving an intervention for a sleep related disorder
Key Trial Info
Start Date :
February 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04529707
Start Date
February 17 2021
End Date
December 31 2024
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15219